These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27717544)

  • 41. Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90.
    Pinzi L; Benedetti R; Altucci L; Rastelli G
    ACS Omega; 2020 May; 5(20):11473-11480. PubMed ID: 32478236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystal structure and synthesis of 17 alpha-(5-bromovaleroyloxy)-16 beta-methylpregna-4,6-diene-3,20-dione.
    Soriano-García M; Ramírez E; Bratoeff E; Cabeza M; Aguirre-Hernández G
    Anal Sci; 2001 Jul; 17(7):911-2. PubMed ID: 11708132
    [No Abstract]   [Full Text] [Related]  

  • 43. HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study.
    Osada T; Crosby EJ; Kaneko K; Snyder JC; Ginzel JD; Acharya CR; Yang XY; Polascik TJ; Spasojevic I; Nelson RC; Hobeika A; Hartman ZC; Neckers LM; Rogatko A; Hughes PF; Huang J; Morse MA; Haystead T; Lyerly HK
    Mol Cancer Ther; 2022 Jan; 21(1):217-226. PubMed ID: 34675120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis and evaluation of novel enzalutamide analogues as potential anticancer agents.
    Bhole RP; Chikhale RV; Wavhale RD; Asmary FA; Almutairi TM; Alhajri HM; Bonde CG
    Heliyon; 2021 Mar; 7(3):e06227. PubMed ID: 33869816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylation Profile of X-Chromosome-Related Genes in Male Breast Cancer.
    Foschini MP; Morandi L; Sanchez AM; Santoro A; Mulè A; Zannoni GF; Varga Z; Moskovszky L; Cucchi MC; Moelans CB; Giove G; van Diest PJ; Masetti R
    Front Oncol; 2020; 10():784. PubMed ID: 32626651
    [No Abstract]   [Full Text] [Related]  

  • 46. Crystal structure and synthesis of 17 alpha-acetoxy-4-bromopregn-4-ene-3,20-dione.
    Soriano-García M; Ramírez E; Bratoeff E; Cabeza M; Aguirre-Hernández G
    Anal Sci; 2002 Aug; 18(8):963-4. PubMed ID: 12200852
    [No Abstract]   [Full Text] [Related]  

  • 47. Androgen receptor variation affects prostate cancer progression and drug resistance.
    McCrea E; Sissung TM; Price DK; Chau CH; Figg WD
    Pharmacol Res; 2016 Dec; 114():152-162. PubMed ID: 27725309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients.
    Del Re M; Biasco E; Crucitta S; Derosa L; Rofi E; Orlandini C; Miccoli M; Galli L; Falcone A; Jenster GW; van Schaik RH; Danesi R
    Eur Urol; 2017 Apr; 71(4):680-687. PubMed ID: 27733296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hematopoietic PBX-Interaction Protein Promotes Breast Cancer Sensitivity to Paclitaxel Through a Microtubule-Dependent Mechanism.
    Yu B; Tian X; Zhang L; Feng R
    DNA Cell Biol; 2016 Nov; 35(11):740-745. PubMed ID: 27754697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer.
    Drazer MW; Stadler WM
    Cancer J; 2016; 22(5):330-333. PubMed ID: 27749326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapy Update for Metastatic Castration-Resistant Prostate Cancer.
    Dinh JA; Baker D; Chahal M
    Consult Pharm; 2016; 31(10):581-592. PubMed ID: 27725068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early use of chemotherapy in metastatic prostate cancer.
    Markowski MC; Carducci MA
    Cancer Treat Rev; 2017 Apr; 55():218-224. PubMed ID: 27720577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abiraterone acetate after progression with enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: a multi-center retrospective analysis.
    Yamada Y; Matsubara N; Tabata KI; Satoh T; Kamiya N; Suzuki H; Kawahara T; Uemura H; Yano A; Kawakami S
    BMC Res Notes; 2016 Oct; 9(1):471. PubMed ID: 27756383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MC1568 inhibits HDAC6/8 activity and influenza A virus replication in lung epithelial cells: role of Hsp90 acetylation.
    Panella S; Marcocci ME; Celestino I; Valente S; Zwergel C; Li Puma DD; Nencioni L; Mai A; Palamara AT; Simonetti G
    Future Med Chem; 2016 Nov; 8(17):2017-2031. PubMed ID: 27739328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. G Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 Axis.
    Nogués L; Reglero C; Rivas V; Salcedo A; Lafarga V; Neves M; Ramos P; Mendiola M; Berjón A; Stamatakis K; Zhou XZ; Lu KP; Hardisson D; Mayor F; Penela P
    EBioMedicine; 2016 Nov; 13():132-145. PubMed ID: 27720394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Author's Reply to Srinivas: "Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer".
    Xu S; De Porre P
    Clin Pharmacokinet; 2017 Feb; 56(2):213-214. PubMed ID: 27815867
    [No Abstract]   [Full Text] [Related]  

  • 57. Comment on: "Modeling the Relationship between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer".
    Srinivas NR
    Clin Pharmacokinet; 2017 Feb; 56(2):211-212. PubMed ID: 27815866
    [No Abstract]   [Full Text] [Related]  

  • 58. Design, synthesis and optimization of bis-amide derivatives as CSF1R inhibitors.
    Ramachandran SA; Jadhavar PS; Miglani SK; Singh MP; Kalane DP; Agarwal AK; Sathe BD; Mukherjee K; Gupta A; Haldar S; Raja M; Singh S; Pham SM; Chakravarty S; Quinn K; Belmar S; Alfaro IE; Higgs C; Bernales S; Herrera FJ; Rai R
    Bioorg Med Chem Lett; 2017 May; 27(10):2153-2160. PubMed ID: 28377059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.
    Sardar S; McNair CM; Ravindranath L; Chand SN; Yuan W; Bogdan D; Welti J; Sharp A; Ryan NK; Knudsen LA; Schiewer MJ; DeArment EG; Janas T; Su XA; Butler LM; de Bono JS; Frese K; Brooks N; Pegg N; Knudsen KE; Shafi AA
    Oncogene; 2024 Oct; 43(43):3197-3213. PubMed ID: 39266679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.
    Sardar S; McNair CM; Ravindranath L; Chand SN; Yuan W; Bogdan D; Welti J; Sharp A; Ryan NK; Schiewer MJ; DeArment EG; Janas T; Su XA; Butler LM; de Bono JS; Frese K; Brooks N; Pegg N; Knudsen KE; Shafi AA
    bioRxiv; 2024 May; ():. PubMed ID: 38766099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.